(-)-Vorozole

CAS No. 132042-69-4

(-)-Vorozole( —— )

Catalog No. M34141 CAS No. 132042-69-4

(-)-Vorozole is an orally active non-steroidal aromatase inhibitor with potency and selectivity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 Get Quote
5MG 409 Get Quote
10MG 604 Get Quote
25MG 908 Get Quote
50MG 1251 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    (-)-Vorozole
  • Note
    Research use only, not for human use.
  • Brief Description
    (-)-Vorozole is an orally active non-steroidal aromatase inhibitor with potency and selectivity.
  • Description
    (-)-Vorozole is an orally active non-steroidal aromatase inhibitor with potency and selectivity. (-)-Vorozole has demonstrated antitumor activity in in vivo experiments. (-)-Vorozole is used in the study of breast cancer.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    P450
  • Recptor
    P450 | Aromatase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    132042-69-4
  • Formula Weight
    324.77
  • Molecular Formula
    C16H13ClN6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [C@H](C=1C=C2C(=CC1)N=NN2C)(C3=CC=C(Cl)C=C3)N4C=NC=N4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Liarozole

    Liarozole is a cytochrome P450 (CYP450) dependent inhibitor, orally active, it also a potent inhibitor of estrogen (via inhibition of aromatase) and testicular androgen synthesis (inhibition of 17 ,20-lyase).

  • Epimedin A1

    Epimedin A1(Hexandraside F) is a flavonoid extracted from Herba Epimedii which is one of commonly used Chinese medicines.

  • Cambinol

    Cambinol is a cell-permeable b-naphthol compound that inhibits the NAD-dependent deacetylase activity of SIRT1/2 (IC50: 56/59 μM, respectively) in a substrate-, but not NAD-, competitive manner.